Vimarsana
Biggest News Aggregation in the World

Page 15 - Eceptor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eceptor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eceptor Today - Breaking & Trending Today

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024 - Vimarsana News

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

NewsMedical speaks with Chao Ma, Ph.D. a Research Assistant Professor at New York University Tandon School of Engineering, ahead of his presentation at SLAS 2024.

Common biomarker test could be misguiding treatment for some Black women with breast cancer - Vimarsana News

Common biomarker test could be misguiding treatment for some Black women with breast cancer

A common test used to decide whether breast cancer patients should get chemotherapy may be making bad recommendations for some Black women, leading them to forgo chemotherapy when it might have helped, according to new research from the University of Illinois Chicago.

Estrogen-positive tumors drive rising breast cancer rates in young women - Vimarsana News

Estrogen-positive tumors drive rising breast cancer rates in young women

According to a study led by researchers at Washington University School of Medicine in St. Louis, diagnoses of breast cancer have increased steadily in women under age 50 over the past two decades, with steeper increases in more recent years.

New insights into why immunotherapy works for some cancers, not others - Vimarsana News

New insights into why immunotherapy works for some cancers, not others

A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis - Vimarsana News

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 1, entitled, "Systematic analysis of the prognostic value and immunological function of LTBR in human cancer."